Delivery Order SPE2DB22D1106-SPE2DB25FEBL0
Award Date
3/4/25
Potential Completion Date
3/5/25
Potential Value
$14K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,337.16, was issued by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp. The contract is for the delivery of LINZESS 290 MCG CAPSULE UU 30S, a pharmaceutical product, with a completion date of December 2, 2024. The contract type is a Delivery Order with a Firm Fixed Price pricing mechanism. This award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major...
This federal contract award, SPE2DB20D1004|SPE2DB24FF6G7, was issued by the Defense Logistics Agency (DLA) to the prime contractor, AmerisourceBergen Drug Corp, for the delivery of LINZESS 290 MCG CAPSULE UU 30S. The contract has a firm fixed price of $1,626.61 and an ultimate completion date of March 19, 2024. This award is not designated as a set-aside contract. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in...
This federal contract award, with ID SPE2DB20D2002|SPE2DB24FL81T, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of the pharmaceutical product LINZESS 72 MCG CAPSULE UU 30S, with a ceiling value of $10,457.45. This is a firm fixed-price delivery order contract with an ultimate completion date of August 28, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen...
This federal contract award, with the ID SPE2DB22D1106|SPE2DB25FDME1, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has a ceiling value of $3,323.89, is a Delivery Order that runs through November 2024. The contract provides for the supply of LINZESS 145 MCG CAPSULE UU 30S, a pharmaceutical product, to support federal government requirements. This award is not designated...
This federal contract award, with an ID of SPE2DB20D2014|SPE2DB25FA78E, was made by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the pharmaceutical product LINZESS 145 MCG CAPSULE UU 30S, with a total ceiling value of $3,417.07. It is a Firm Fixed Price Delivery Order contract, with an ultimate completion date of January 14, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that...
This federal contract award, with an ID of SPE2DB20D1110|SPE2DB24FK28G, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $3,843.66 firm fixed-price delivery order is for the supply of LINZESS 290 MCG CAPSULE UU 30S, a pharmaceutical product. The contract has an ultimate completion date of June 6, 2024 and was awarded on June 5, 2024. No set-aside designation was used. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and...
This federal contract award, with ID SPE2DB20D1100|SPE2DB25FZ57W, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $2,394.39, is a Firm Fixed Price Delivery Order for the supply of LINZESS 145 MCG CAPSULE UU 30S, a pharmaceutical product. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of LINZESS 290 MCG CAPSULE UU 30S. The contract has a ceiling value of $5,301.00 and an ultimate completion date of July 9, 2024. It is a firm fixed-price delivery order, without any set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order valued at $7,982.53 for the pharmaceutical product LINZESS 290 MCG CAPSULE UU 30S. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This federal contract award, valued at $1,654.82, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LINZESS 290 MCG CAPSULE, a pharmaceutical product. The contract has an ultimate completion date of December 30, 2024, and is a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant...